Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842517 · ClinicalTrials.gov registry record · Phase 1
Long Term Maintenance of Drug Abstinence
A Phase 1 study of Cocaine Dependence and Cocaine Abuse, sponsored by Treatment Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT00842517 is a Phase 1 study of Cocaine Dependence and Cocaine Abuse that has completed, run by Treatment Research Institute. The registered enrollment target is 166 participants, below the 294-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00842517, a Phase 1 study of Cocaine Dependence and Cocaine Abuse, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a model for long-term maintenance of behavior change by examining the effects of extending the duration of contingency management (CM) for drug abuse on long-term abstinence outcomes. The primary hypothesis is that the Extended (36 week) CM group will have better long-term outcomes as exhibited by greater rates of abstinence at each follow-up assessment as compared to the Standard (12 week) CM group.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
Study Locations (1)
Pennsylvania
- Parkside Recovery - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842517
The ClinicalTrials.gov registry entry for NCT00842517 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 294-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (44% lower). The listed sponsor is Treatment Research Institute, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cocaine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.
NCT00842517 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00842517 about?
NCT00842517 is a clinical study titled "Long Term Maintenance of Drug Abstinence". The purpose of this study is to develop a model for long-term maintenance of behavior change by examining the effects of extending the duration of contingency management (CM) for drug abuse on long-term abstinence outcomes. The primary hypothesis is that the Extended (36 week) CM group will have bet...
What is the current status of trial NCT00842517?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 166 participants. The study started on 2004-09. Estimated completion is 2008-08.
What conditions does trial NCT00842517 study?
This clinical trial studies the following conditions: Cocaine Dependence, Cocaine Abuse.
What interventions are being tested in trial NCT00842517?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00842517?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00842517 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
RECRUITING · Phase 1
-
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS
COMPLETED · Phase 1
-
Complementary Combination Therapy for Cocaine Dependence
COMPLETED · Phase 1
-
Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues
COMPLETED · Phase 1
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
COMPLETED · Phase 1
-
Caffeine and Cocaine
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.